Vulvar Inspection During Cervical Cancer Screening Procedures: The Ugly Reality

Mario Preti,Karin Anderson,Ezio Venturino,Tiziano Maggino,Francesca Carozzi,Eleonora Robba,Pedro Vieira-Baptista,Fulvio Borella,Laura Barchi,Federica Bevilacqua,Niccolò Gallio,Ilaria Barbierato,Benedetta Pollano,Camilla Cavallero,Samuel Gardner-Medwin,Chiara Benedetto,Lauro Bucchi
DOI: https://doi.org/10.1097/lgt.0000000000000832
2024-07-30
Journal of Lower Genital Tract Disease
Abstract:Abstract Vulvar examination during procedures for cervical carcinoma screening (CCS) can be a valid chance for early diagnosis of vulvar diseases and precancerous lesions. With this aim an online questionnaire was sent to the members of the Italian Cervical Carcinoma Screening Group (GISCi) from either first level group (FLG, Pap/human papillomavirus test sampling) or second level group (SLG, colposcopy and treatments) to assess if and how vulvar examination was performed. 86% of FLG and 90.2% of SLG report performing vulvar examination prior to CCS procedures. 15% of SLG cannot manage basic vulvar diseases and they refer patients to specialized center. 54.3% underline lack of standardized protocol in case of vulvar disease detection. Despite most health care professionals report examining the vulva during CCS procedures, vulvar cancer early diagnosis is still challenging.
obstetrics & gynecology
What problem does this paper attempt to address?